131 results
Page 4 of 7
CORRESP
lb0ftg7
16 Nov 18
Correspondence with SEC
12:00am
UPLOAD
rupwhypno27vtuk49t
15 Nov 18
Letter from SEC
12:00am
DEFM14A
k0vyuqzk4vximk ko
6 Nov 18
Proxy related to merger
12:00am
424B3
wgias9i cz
5 Nov 18
Prospectus supplement
3:51pm
S-4/A
rk3sh9lhq1gj48 hek77
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-99.1
od2pmf 5egj
1 Nov 18
OvaScience and Millendo Therapeutics Provide Update on Merger Agreement and Financing
5:01pm
425
EX-99.1
bg6x3sjkb 16ijj2
1 Nov 18
Business combination disclosure
5:00pm
8-K
EX-99.2
vkibljj
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-99.3
mlupza gvtkhi6q3x3
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-99.4
5yu3p2ogs ms6aauoeyg
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-99.1
7v6qkw6
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-99.3
99uyee
9 Aug 18
Business combination disclosure
5:17pm
425
EX-99.4
afh7ur7wh3f11rwpt6
9 Aug 18
Business combination disclosure
5:17pm
425
EX-99.1
3x79 aukre4j0cdg8jr
9 Aug 18
Business combination disclosure
5:17pm
425
EX-99.2
5phsll8nnw0rm8x3yey
9 Aug 18
Business combination disclosure
5:17pm